Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone LymphomaB-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, neoplasmActive, not recruitingPhase 32026-07-23NCT04212013

2 results · Page 1 of 1

Swipe the table sideways for more columns.

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
George Washington Cancer CenterWashington D.C.United States2
Mayo Clinic Cancer CenterRochesterUnited States16
Memorial Sloan Kettering Basking RidgeBasking RidgeUnited States189
Memorial Sloan Kettering BergenMontvaleUnited States193
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Memorial Sloan Kettering CommackCommackUnited States189
Memorial Sloan Kettering MonmouthMiddletownUnited States206
Memorial Sloan Kettering NassauUniondaleUnited States193
Memorial Sloan Kettering WestchesterHarrisonUnited States204
Moffitt Cancer CenterTampaUnited States523